Ayman A. Mohamed
Chief Technology OfficerDr. Ayman A. Mohamed, M.D is Co-Founder of Precipio Diagnostics. He serves as Chief Technology Officer at Precipio, Inc. and joined the company in 2011. He served as Vice President of R&D and laboratory’s Technical Director at Precipio, Inc. In this dual role, Ayman is responsible for the entire process from conceptualization and invention of proprietary technologies, through design and development, economic cost analysis and modeling, testing and validation; and finally, the technical implementation of the technologies for clinical use in Precipio’s laboratories. Ayman has been responsible for the development and introduction of ground-breaking products such as IV-Cell™, HemeScreen® and ICE-COLD PCR™. He had been Senior Vice President of R&D and Laboratory Operations of Precipio, Inc. in June 2017. He served as Vice President of Precipio Diagnostics, LLC since 2011 and also served as its Chief Compliance Officer. Prior to Precipio, Ayman served in various technical and research positions in both commercial diagnostic companies as well as academic centers such as Yale University. Ayman is also a certified CAP inspector. He holds an MD and a Masters in Human Genetics from the University of Alexandria, Egypt.
Positions
- Company NamePrecipio, Inc.Stock CodePRPOPositionChief Technology OfficerColleagues
- IDIlan DanieliFounder, President, CEO & Director
- RARichard Alvin SandbergIndependent Chairman of the Board
- AZAhmed Zaki SabetChief Operating Officer
- MGMatthew GageChief Financial Officer
- MCMiri Chiko-RadomskiChief Legal Counsel & People Officer
- JCJeffrey CossmanIndependent Director
- DSDavid Seth CohenIndependent Director
- KDKathleen D. LaPorteIndependent Non Executive Director
